FingerMotion, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FingerMotion, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $35.61M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $35.79M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $34.05M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $22.93M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $16.68M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $9.13M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $1.47M | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | $453.5K | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | $67.7K | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | $14.6K | Jun 14, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $2.76M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $3.86M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $2.32M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $2.81M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $1.65M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $965.8K | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $343.0K | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | $18.8K | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | $15.0K | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | $8.0K | Jun 14, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($5.11M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($3.81M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($7.54M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($4.94M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($4.38M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($3.00M) | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($2.91M) | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | ($1.75M) | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | ($158.4K) | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | ($13.1K) | Jun 14, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($5.95M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($3.82M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($6.67M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($4.87M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($4.23M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($3.07M) | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($2.56M) | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | ($1.75M) | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | ($158.4K) | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | ($12.8K) | Jun 14, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $632.8K | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $699.6K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $797.5K | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $923.4K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $552.3K | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $390.3K | May 28, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($8.18M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($7.33M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($8.61M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($5.85M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($4.27M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($2.56M) | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($718.3K) | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | ($1.61M) | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | $13.3K | Aug 7, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $4.1K | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $376 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $74.8K | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $14.4K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $17.0K | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $17.5K | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $11.7K | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | $1.7K | Jun 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $48.82M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $18.45M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $17.55M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $10.37M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $7.34M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $5.88M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $4.44M | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | $439.8K | Jun 13, 2019 |
| FY2016 | Feb 29, 2016 | $2.2K | May 31, 2016 |
| FY2016 | Feb 28, 2015 | $1.0K | May 31, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $35.16M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $6.75M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $4.57M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $5.28M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $5.23M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $6.17M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $3.85M | Jul 14, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $13.65M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $11.69M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $12.96M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $5.08M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $2.11M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($298.6K) | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $586.0K | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | ($102.6K) | Jun 13, 2019 |
| FY2019 | Feb 28, 2017 | ($157.2K) | Jun 13, 2019 |
| FY2017 | Feb 29, 2016 | ($37.7K) | Jun 14, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($34.19M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($29.07M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($24.69M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($17.15M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($12.21M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($7.83M) | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($4.82M) | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | ($1.91M) | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | ($158.4K) | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | ($103.9K) | Jun 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.13M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $1.52M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $9.24M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $461.9K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $850.7K | May 31, 2022 |
| FY2022 | Feb 29, 2020 | $102.9K | May 31, 2022 |
| FY2021 | Feb 28, 2019 | $1.34M | May 28, 2021 |
| FY2020 | Feb 28, 2018 | $10.6K | Jul 14, 2020 |
| FY2019 | Feb 28, 2017 | $13.3K | Jun 13, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 0 | May 30, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 31, 2022 |
| FY2021 | Feb 29, 2020 | 0 | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 0 | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | 0 | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | 0 | Aug 7, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 0 | May 30, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 31, 2022 |
| FY2021 | Feb 29, 2020 | 0 | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 0 | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | 0 | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | 0 | Aug 7, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 57.14M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 52.55M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 49.43M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 42.63M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | 38.90M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | 25.85M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 24.76M | Jul 14, 2020 |
| FY2019 | Feb 28, 2018 | 17.43M | Jun 13, 2019 |
| FY2018 | Feb 28, 2017 | 12.00M | Aug 7, 2018 |
| FY2017 | Feb 29, 2016 | 10.31M | Jun 14, 2017 |